Cancer Treatment Costs Surge ACA May Offer Limited Relief Amid Rising Expenses Stellantis Turnaround Prediction Market Regulation and Oura IPO Lead Morning Market Briefing Vestas Wind Systems Shares Slide After Margin Guidance Revision Jim Cramer Highlights Diversification Opportunities Beyond AI in Monthly Portfolio Review Treasury Yields Dip Slightly as Iran Peace Deal Optimism Tempers Market Sentiment SpaceX OpenAI Could Surpass Berkshire Hathaway on First Trading Day Polymarket Shows ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains CLW Q1 2026 Earnings EPS Beats Estimates Despite Negative Earnings Stock Edges Lower HR Earnings Overview 20260522 GNLN Q2 2023 Earnings Massive EPS Miss with No Revenue Disclosed Stock Rises 435 LGIH Q1 2026 Earnings Massive EPS Surprise Driven by Strong Profitability PLOW Q1 2026 Earnings Earnings Surge 161 Above Estimates as Profitability Surprises Cigna Group CI Holds Steady Near Support as Healthcare Sector Shows Resilience Logitech LOGI Surges 646 Key Levels to Watch After Breakout Move Splash Beverage Group SBEV Slides 357 to 016 Testing Key Support at 015 Blackrock Health Sciences Trust BME Edges Higher Testing Key Resistance Zone TriplePoint Venture Growth BDC TPVG Slips 21 as Pressure Mounts Near Key Support SoftBank Group Surges 20 Amid Strong Nvidia Earnings and AI Momentum FUBO Q1 2026 Earnings Strong EPS Beat Drives Narrower Loss Yet Stock Declines SpaceX Delays Starship V3 Test Flight Rescheduled for Friday Amid MultiBillion Dollar Development Intuit to Cut 17 of Workforce Shifting Focus to AI Amid Tax Business Disruption Concerns Quantum Computing Threatens Bitcoin Security Industry Warns Threat Has Shifted From Theoretical to Credible UK Chancellor Reeves Proposes VAT Cut on Summer Attractions to 5 Amid CostofLiving Relief Package Crypto Market Sees Over 400M in Liquidations as Bitcoin Ethereum Slide on Macro Concerns and ETF Outflows TECX Q1 2026 Earnings WiderthanExpected Loss Amidst PreRevenue Stage Nuvectis Pharma NVCT Holds Near Support After Modest Uptick